NeurologyLive Friday 5 — June 11, 2021


Take 5 minutes to catch up on NeurologyLive's highlights from the week ending June 11, 2021.

Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: It's Complicated: Why Aducanumab's Approval Raises More Questions Than Answers

Alzheimer disease experts Richard S. Isaacson, MD, and Marc E. Agronin, MD, discuss the recent aducanumab approval and some of the clinical community's concerns.

2: Mind Moments Ep. 39: A Controversial FDA Decision

"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with a number of experts in Alzheimer disease to gauge their reaction to the controversial FDA decision to approve aducanumab (Aduhelm; Biogen) and the potential impact that this first approval since 2003 may have on research, policy, and treatment.

3: NeuroVoices: Andrew Blumenfeld, MD, on a Combination Approach to Treating Chronic Migraine

The director for the Headache Center of Southern California discussed his research presented at the American Headache Society's 2021 Annual Scientific Meeting, which evaluated a combination of onabotunlinumtoxinA and calcitonin gene-related peptide targeting agents in patients with chronic migraine.

4: Importance of Early Diagnosis for Dravet Syndrome

In this segment of the Peer Exchange, "Redefining Treatment Outcomes in Dravet Syndrome," Joseph Sullivan, MD; Trevor J. Resnick, MD; Elizabeth A. Thiele MD, PhD; and Elaine C. Wirrell, MD, offer panelists discuss recommendations for the diagnosis, treatment, and management of patients with the rare epilepsy syndrome.

5: Best Practices for Patient Compliance in Epilepsy Treatment

In this segment of the Insights series, "Patient Compliance with Treatments for Epilepsy," Imad Michel Najm, MD, discusses various factors to consider when diagnosing epilepsy in patients, such as when to start drug therapy as well as patient resistance to medications, and shares his best practices for improving compliance.


If you missed your chance to see the May broadcast of our free webinar series, "The Ever-Changing Face of Multiple Sclerosis," put on in partnership with the Consortium of Multiple Sclerosis Centers, don't fret! You can join Ahmed Obeidat, MD, PhD; Mitch Freedman, MD; and Suma Shah, MD, and others as they discuss the evolution of therapeutics for the treatment of multiple sclerosis. Additionally, you can register for the live broadcast of the third installment on June 16, 2021, for a detailed discussion on the evolution of diagnosis and treating multiple sclerosis care during a pandemic featuring Obeidat; Anne Cross, MD; and Gloria von Geldern, MD.

To register for the next broadcast for free, click here.

To view the enduring version of either of the first two programs, click here for our Future Leaders in Neurology section.

Related Videos
Jessica Ailani, MD
Frederic Schaper, MD, PhD
Jaime Imitol, MD
Jason M. Davies, MD, PhD
Carolyn Bernstein, MD
Prashanth Rajarajan, MD, PhD
Mandy Alhajj, DO, James Dolbow, DO & Neel Fotedar, MD
© 2024 MJH Life Sciences

All rights reserved.